Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus esketamine vs dexmedetomidine plus sufentanil for postoperative analgesia in ERAS surgery
ChiCTR2100049398Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Sep 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, esketamine and sufentanil in postoperative pain (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Interleukin-6 level, Visual analogue scale for pain and 6 more. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
dexmedetomidineesketaminesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100049398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049398.